Deborah P Merke

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

The Journal of clinical endocrinology and metabolism

Molecular genetics & genomic medicine

Journal of the Endocrine Society

The New England journal of medicine

Columbia University (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

Columbia University Sep 1o 1983 - Jan 22o 1986

United States

MSC :: Biostatistics

Publications

Myrto Eleni Flokas, Paul Wakim, Sarah Kollender, Ninet Sinaii, Deborah P Merke
Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia. The Journal of clinical endocrinology and metabolism (2023)
Kyriakie Sarafoglou, Deborah P Merke, Nicole Reisch, Hedi L Claahsen-van der Grinten, Henrik Falhammar, Richard J Auchus
Interpretation of Steroid Biomarkers in 21-Hydroxylase Deficiency and Their Use in Disease Management. The Journal of clinical endocrinology and metabolism (2023)
Qizong Lao, Deepika D'Cunha Burkardt, Sarah Kollender, Fabio Rueda Faucz, Deborah P Merke
Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera. Molecular genetics & genomic medicine (2023)
Ashwini Mallappa, Deborah P Merke
Management challenges and therapeutic advances in congenital adrenal hyperplasia. Nature reviews. Endocrinology 18 (6) (2022)
Jacqueline Yano Maher, Veronica Gomez-Lobo, Deborah P Merke
The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum. Reviews in endocrine & metabolic disorders (2022)
Ahmed Torky, Ninet Sinaii, Smita Jha, Jay Desai, Diala El-Maouche, Ashwini Mallappa, Deborah P Merke
Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia. The Journal of clinical endocrinology and metabolism 106 (12) (2021)
Qizong Lao, Deborah P Merke
Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clirnical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". The Journal of clinical endocrinology and metabolism 106 (7) (2021)
Qizong Lao, Deborah P Merke
Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras. European journal of human genetics : EJHG 29 (7) (2021)
Maggie Dwiggins, Brittany Brookner, Kylie Fowler, Padmasree Veeraraghavan, Veronica Gomez-Lobo, Deborah P Merke
Multidimensional Aspects of Female Sexual Function in Congenital Adrenal Hyperplasia: A Case-Control Study. Journal of the Endocrine Society 4 (11) (2020)
Deborah P Merke, Richard J Auchus
Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency. The New England journal of medicine 383 (13) (2020)
Qizong Lao, Ashwini Mallappa, Fabio Rueda Faucz, Elizabeth Joyal, Padmasree Veeraraghavan, Wuyan Chen, Deborah P Merke
A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia. Molecular genetics & genomic medicine 9 (2) (2020)
Smita Jha, Adina F Turcu, Ninet Sinaii, Brittany Brookner, Richard J Auchus, Deborah P Merke
11-Oxygenated Androgens Useful in the Setting of Discrepant Conventional Biomarkers in 21-Hydroxylase Deficiency. Journal of the Endocrine Society 5 (2) (2020)
Diala El-Maouche, Fady Hannah-Shmouni, Ashwini Mallappa, Courtney J Hargreaves, Nilo A Avila, Deborah P Merke
Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia. Clinical endocrinology 91 (2) (2019)
Qizong Lao, Marcia Des Jardin, Rahul Jayakrishnan, Monique Ernst, Deborah P Merke
Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human genetics 137 (11-12) (2018)

Deborah P Merke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Deborah P Merke